BioNTech SE
BNTX
NASDAQ. Currency in USD
168.56 -6.69 ( -3.82% )
Free financials are limited to the past 5 years. With Premium you can see +30 years of financial data. Upgrade now to premium for only $2.99!
| Date | 2021 | 2020 | 2019 | 2018 |
| Gross Profit | 15.12B | 422.99M | 91.23M | 113.89M |
| Revenue | 18.98B | 482.32M | 108.59M | 127.58M |
| Cost Of Revenue | 3.86B | 59.33M | 17.36M | 13.69M |
| Cost Of Goods And Services Sold | 3.86B | 59.33M | 17.36M | 13.69M |
| Operating Income | 15.28B | -82.42M | -181.52M | -53.85M |
| Selling General And Administrative | 278.50M | 86.91M | 40.69M | 24.05M |
| Research And Development | - | 647.06M | 226.47M | 143.04M |
| Operating Expenses | 200.10M | 512.41M | 272.75M | 167.74M |
| Investment Income Net | - | - | - | - |
| Net Interest Income | -25.80M | -3.49M | -263,000 | 227,000 |
| Interest Income | 1.50M | 1.56M | 1.78M | 2.00M |
| Interest Expense | 5.40M | 2.00M | 1.72M | 1.72M |
| Non Interest Income | - | - | - | - |
| Other Non Operating Income | - | - | 0 | 0 |
| Depreciation | - | - | - | - |
| Depreciation And Amortization | 75.20M | 38.74M | 33.90M | 21.98M |
| Income Before Tax | 15.05B | -145.80M | -179.44M | -47.66M |
| Income Tax Expense | 4.75B | -161.00M | -268,000 | 600,000 |
| Interest And Debt Expense | - | - | - | - |
| Net Income From Continuing Operations | 10.29B | 15.20M | -179.17M | -48.26M |
| Comprehensive Income Net Of Tax | - | - | - | - |
| Ebitda | 15.13B | -105.06M | -143.71M | -23.71M |
| Ebit | 15.05B | -143.80M | -177.61M | -45.70M |
| Net Income | 10.29B | 15.20M | -179.06M | -48.02M |